NeoGenomics Stock News

The company released promising earnings results.

The SEC's crackdown has spooked crypto traders.

Upgrades According to Alembic Global, the prior rating for Woodward Inc (NASDAQ:WWD) was changed from Neutral to Overweight. Woodward earned $0.49 in the first quarter, compared to $0.56 in the year-a

NeoGenomics (NASDAQ:NEO) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 1 0 0 Last 30D 1

Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force. NeuroSense Therapeutic

The mean of analysts' price targets for NeoGenomics (NEO) points to a 40.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analy

What started as a seemingly innocuous leadership transition at one of the country's leading molecular diagnostic firms, NeoGenomics, Inc., has evolved into something much more chaotic. After the depar

NEO Q3 results carry signs of stability after tumultuous six months, which saw the company running without a CEO. It is too early to assess the performance of the current CEO, given that Q3 results ar

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session. Inotiv, Inc. (NASDAQ: NOTV) shares tumbled 46.9% t

The cancer screening company showed its turnaround may be working.

The cancer screening company showed its turnaround may be working.

Neo Performance Materials Inc. (OTCPK:NOPMF) Q3 2022 Earnings Conference Call November 11, 2022 10:00 AM ET Company Participants Ali Mahdavi – Head-Investor Relations Constantine Karayannopoulos –

Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to $15

Within the last quarter, NeoGenomics (NASDAQ:NEO) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 0 0 0 Last 30D

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. TaskUs, Inc. (NAS